Reports First Quarter 2020 Results NYSE:MDT, NASDAQ:NTAP, NYSE:TD, NYSE:NFH

0
126

MEDTRONIC (NYSE:MDT) EARNINGS INFORMATION (NYSE:MDT)

Medtronic last issued its quarterly earnings results on August 25th, 2020. The medical technology company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.41. The company earned $6.51 billion during the quarter, compared to analyst estimates of $5.48 billion. Its revenue was down 13.2% on a year-over-year basis. Medtronic has generated $4.59 earnings per share over the last year and currently has a price-to-earnings ratio of 33.0. Medtronic has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 17th, 2020 based off prior year’s report dates.

HOW HAS MEDTRONIC’S STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NYSE:MDT)

Medtronic’s stock was trading at $92.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MDT stock has increased by 16.7% and is now trading at $107.86.

NETAPP (NASDAQ:NTAP) EARNINGS INFORMATION (NASDAQ:NTAP)

NetApp last posted its earnings results on August 26th, 2020. The data storage provider reported $0.73 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.32. The company had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.15 billion. Its quarterly revenue was up 5.4% compared to the same quarter last year. NetApp has generated $3.53 earnings per share over the last year and currently has a price-to-earnings ratio of 13.2. NetApp has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, November 11th, 2020 based off prior year’s report dates.

HOW HAS NETAPP’S STOCK PRICE BEEN IMPACTED BY CORONAVIRUS? (NASDAQ:NTAP)

NetApp’s stock was trading at $40.45 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NTAP stock has increased by 13.1% and is now trading at $45.74.

TORONTO-DOMINION BANK (NYSE:TD) EARNINGS INFORMATION (NYSE:TD)

Toronto-Dominion Bank last announced its quarterly earnings data on August 27th, 2020. The bank reported $1.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.75 by $0.50. The company earned $10.67 billion during the quarter, compared to the consensus estimate of $9.99 billion. Its quarterly revenue was up 1.6% compared to the same quarter last year. Toronto-Dominion Bank has generated $5.03 earnings per share over the last year and currently has a price-to-earnings ratio of 11.7. Toronto-Dominion Bank has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, December 3rd, 2020 based off prior year’s report dates.

HOW HAS TORONTO-DOMINION BANK’S STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)? (NYSE:TD)

Toronto-Dominion Bank’s stock was trading at $42.12 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TD stock has increased by 19.2% and is now trading at $50.20.

NEW FRONTIER HEALTH (NYSE:NFH) EARNINGS INFORMATION (NYSE:NFH)

New Frontier Health last announced its quarterly earnings results on May 27th, 2020. The reported ($0.17) earnings per share (EPS) for the quarter. The firm had revenue of $60.86 million for the quarter. New Frontier Health has generated $0.00 earnings per share over the last year. New Frontier Health has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 26th, 2020 based off prior year’s report dates.

DO WALL STREET ANALYSTS RECOMMEND INVESTORS BUY SHARES OF NEW FRONTIER HEALTH? (NYSE:NFH)

1 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for New Frontier Health in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of “Buy.”
.